Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1936 1
1946 1
1949 1
1951 1
1955 1
1961 1
1962 1
1963 2
1964 2
1965 2
1967 1
1968 1
1969 1
1970 1
1971 3
1972 3
1973 1
1974 1
1975 2
1976 2
1983 1
1985 1
1986 2
1987 1
1989 2
1991 4
1992 4
1993 1
1994 4
1996 2
1997 1
1998 3
2001 1
2003 1
2004 1
2005 2
2006 2
2007 10
2008 12
2009 8
2010 8
2011 2
2012 3
2013 6
2014 3
2015 6
2016 10
2017 10
2018 9
2019 19
2020 11
2021 23
2022 19
Text availability
Article attribute
Article type
Publication date

Search Results

199 results
Results by year
Filters applied: . Clear all
Page 1
A Guideline for Reporting Mediation Analyses of Randomized Trials and Observational Studies: The AGReMA Statement.
Lee H, Cashin AG, Lamb SE, Hopewell S, Vansteelandt S, VanderWeele TJ, MacKinnon DP, Mansell G, Collins GS, Golub RM, McAuley JH; AGReMA group, Localio AR, van Amelsvoort L, Guallar E, Rijnhart J, Goldsmith K, Fairchild AJ, Lewis CC, Kamper SJ, Williams CM, Henschke N. Lee H, et al. Among authors: goldsmith k. JAMA. 2021 Sep 21;326(11):1045-1056. doi: 10.1001/jama.2021.14075. JAMA. 2021. PMID: 34546296 Free PMC article.
Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies.
Place AE, Goldsmith K, Bourquin JP, Loh ML, Gore L, Morgenstern DA, Sanzgiri Y, Hoffman D, Zhou Y, Ross JA, Prine B, Shebley M, McNamee M, Farazi T, Kim SY, Verdugo M, Lash-Fleming L, Zwaan CM, Vormoor J. Place AE, et al. Among authors: goldsmith k. Future Oncol. 2018 Sep;14(21):2115-2129. doi: 10.2217/fon-2018-0121. Epub 2018 Mar 29. Future Oncol. 2018. PMID: 29595064 Free article. Clinical Trial.
Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistance.
Çoku J, Booth DM, Skoda J, Pedrotty MC, Vogel J, Liu K, Vu A, Carpenter EL, Ye JC, Chen MA, Dunbar P, Scadden E, Yun TD, Nakamaru-Ogiso E, Area-Gomez E, Li Y, Goldsmith KC, Reynolds CP, Hajnoczky G, Hogarty MD. Çoku J, et al. Among authors: goldsmith kc. EMBO J. 2022 Apr 19;41(8):e108272. doi: 10.15252/embj.2021108272. Epub 2022 Feb 25. EMBO J. 2022. PMID: 35211994 Free PMC article.
Quinidine-induced thrombocytopenia.
Libman LJ, Goldsmith KL. Libman LJ, et al. Among authors: goldsmith kl. Proc R Soc Med. 1972 Jul;65(7):590. Proc R Soc Med. 1972. PMID: 4673594 Free PMC article. No abstract available.
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium.
DuBois SG, Granger MM, Groshen S, Tsao-Wei D, Ji L, Shamirian A, Czarnecki S, Goodarzian F, Berkovich R, Shimada H, Villablanca JG, Vo KT, Pinto N, Mosse YP, Maris JM, Shusterman S, Cohn SL, Goldsmith KC, Weiss B, Yanik GA, Twist CJ, Irwin MS, Haas-Kogan DA, Park JR, Marachelian A, Matthay KK. DuBois SG, et al. Among authors: goldsmith kc. J Clin Oncol. 2021 Nov 1;39(31):3506-3514. doi: 10.1200/JCO.21.00703. Epub 2021 Jul 16. J Clin Oncol. 2021. PMID: 34270348 Clinical Trial.
Discernment of mediator and outcome measurement in the PACE trial.
Carr E, Vitoratou S, Chalder T, Goldsmith K. Carr E, et al. Among authors: goldsmith k. J Psychosom Res. 2021 Oct;149:110595. doi: 10.1016/j.jpsychores.2021.110595. Epub 2021 Aug 13. J Psychosom Res. 2021. PMID: 34438356 Clinical Trial.
Response to the editorial by Dr Geraghty.
White PD, Chalder T, Sharpe M, Angus BJ, Baber HL, Bavinton J, Burgess M, Clark LV, Cox DL, DeCesare JC, Goldsmith KA, Johnson AL, McCrone P, Murphy G, Murphy M, O'Dowd H, Potts L, Walwyn R, Wilks D. White PD, et al. Among authors: goldsmith ka. J Health Psychol. 2017 Aug;22(9):1113-1117. doi: 10.1177/1359105316688953. Epub 2017 Jan 24. J Health Psychol. 2017. PMID: 28805524
199 results